Besides, both the gain‐ and loss‐of‐function assays disclosed that miR‐646 suppressed the proliferation and invasion of NSCLC cells in vitro and in vivo by downregulating fibroblast growth factor 2 (FGF2) and cyclin D2 (CCND2). The gene discussed is CCND2; the disease is non-small cell lung carcinoma.